Literature DB >> 22059423

The convergence of type 1 and type 2 diabetes in childhood: the accelerator hypothesis.

T J Wilkin1.   

Abstract

It seems likely that type 1 and type 2 diabetes lie at different points of the same spectrum, separated by the misunderstanding that one belongs to childhood and the other to adulthood. The spectrum is that of tempo--the rate at which beta cell function is lost over time. A combination of beta cell up-regulation (insulin demand, largely determined by obesity) and the genetically-determined immune response to it ('autoimmunity') determines tempo, ranging from slow to fast with every variant in between. There is good evidence that people who go on to develop type 1 (fast) diabetes are, like those who develop type 2 (slow diabetes), insulin resistant, and overwhelming evidence that body mass plays a key role. The prevention of type 1 diabetes may lie in weight restriction from an early age.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22059423     DOI: 10.1111/j.1399-5448.2011.00831.x

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  18 in total

1.  Utility of diabetes-associated autoantibodies for classification of new onset diabetes in children and adolescents.

Authors:  Julia E von Oettingen; Joseph I Wolfsdorf; Henry A Feldman; Erinn T Rhodes
Journal:  Pediatr Diabetes       Date:  2015-08-28       Impact factor: 4.866

2.  Incidence of type 1 diabetes mellitus during 26 years of observation and prevalence of diabetic ketoacidosis in the later years.

Authors:  Malgorzata Wojcik; Malgorzata Sudacka; Barbara Wasyl; Marta Ciechanowska; Joanna Nazim; Malgorzata Stelmach; Jerzy B Starzyk
Journal:  Eur J Pediatr       Date:  2015-04-17       Impact factor: 3.183

Review 3.  Is autoimmunity or insulin resistance the primary driver of type 1 diabetes?

Authors:  Terence J Wilkin
Journal:  Curr Diab Rep       Date:  2013-10       Impact factor: 4.810

4.  Physical activity and progression to type 1 diabetes in children and youth with islet autoimmunity: The diabetes autoimmunity study in the young.

Authors:  Janet Snell-Bergeon; Kathleen Waugh; Fran Dong; Andrea Steck; Jill Norris; Marian Rewers
Journal:  Pediatr Diabetes       Date:  2022-03-07       Impact factor: 3.409

5.  Factors related to glycemic control in children and adolescents with type 1 diabetes mellitus in Isfahan, Iran.

Authors:  Mahin Hashemipour; Silva Hovsepian; Nafiseh Mozafarian; Zohreh Motaghi; Elahe Izadikhah; Mohammad Reza Maracy
Journal:  J Diabetes Metab Disord       Date:  2021-08-11

6.  Association of antibiotics exposure within the first 2 years after birth with subsequent childhood type 1 diabetes.

Authors:  Dahye Lee; Seulggie Choi; Jooyoung Chang; Young Jun Park; Jae Hyun Kim; Sang Min Park
Journal:  Endocrine       Date:  2022-05-13       Impact factor: 3.925

7.  Changes from 1986 to 2018 in the prevalence of obesity and overweight, metabolic control and treatment in children with type 1 diabetes mellitus in a Mediterranean area of Southeast Spain.

Authors:  María Teresa Pastor-Fajardo; María Teresa Fajardo-Giménez; Vicente María Bosch-Giménez; José Pastor-Rosado
Journal:  BMC Pediatr       Date:  2022-05-12       Impact factor: 2.567

8.  Insulin resistance and associated factors in patients with Type 1 Diabetes.

Authors:  Mônica Maria Teixeira; Maria de Fátima Haueisen Sander Diniz; Janice Sepúlveda Reis; Teresa Cristina Abreu Ferrari; Maria Goretti Bravim de Castro; Bruna Polonio Teixeira; Isabella Cristina da Silva Arantes; Danielle Marques Bicalho; Rodrigo Bastos Fóscolo
Journal:  Diabetol Metab Syndr       Date:  2014-12-01       Impact factor: 3.320

9.  Preserved C-peptide levels in overweight or obese compared with underweight children upon diagnosis of type 1 diabetes mellitus.

Authors:  Hyeoh Won Yu; Yun Jeong Lee; Won Im Cho; Young Ah Lee; Choong Ho Shin; Sei Won Yang
Journal:  Ann Pediatr Endocrinol Metab       Date:  2015-06-30

Review 10.  Obesity in Patients with Type 1 Diabetes: Links, Risks and Management Challenges.

Authors:  Nuria Vilarrasa; Patricia San Jose; Miguel Ángel Rubio; Albert Lecube
Journal:  Diabetes Metab Syndr Obes       Date:  2021-06-21       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.